gw0742 and Diabetic-Retinopathy

gw0742 has been researched along with Diabetic-Retinopathy* in 1 studies

Other Studies

1 other study(ies) available for gw0742 and Diabetic-Retinopathy

Article	Year
Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders. Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6 Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin	2020

Article

Year

Evolution of a 4-Benzyloxy-benzylamino Chemotype to Provide Efficacious, Potent, and Isoform Selective PPARα Agonists as Leads for Retinal Disorders.

Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6

Topics: Animals; Benzylamines; Capillary Permeability; Cell Line; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Drug Discovery; Humans; PPAR alpha; Rats; Retinal Diseases; Streptozocin

2020